Tuesday, May 4, 2021
David Anderson is an Assistant Professor of Analytics at the Villanova School of Business. He received his Ph.D. in Operations Management and Statistics from the Robert H. Smith School of Business at the University of Maryland. His research focuses on developing and applying analytics techniques across a range of business domains, with a specific focus on healthcare. His research has appeared in journals like Nature, Production and Operations Management, PharmacoEconomics, Decision Science, and Health Care Management Science. In addition to academic research, he spent five years working as a cloud analytics developer for the Department of Defense, working in information security.
Dr. Hilal Atasoy is an Assistant Professor at the Rutgers Business School, Rutgers University. Previously, she was an Assistant Professor at the Fox School of Business, Temple University. She has a Ph.D. and a Master’s degree in Economics from the University of Illinois, Urbana-Champaign. Her research analyzes how information systems and the associated flow of information across providers affect healthcare costs and quality, network externalities of health information technology, and the effects of digital protocols on clinical decision-making. Dr. Atasoy’s research has been published in leading outlets such as Management Science, Information Systems Research, Industrial and Labor Relations Review and The Annual Review of Public Health.
Jonathan Doh, PhD, is Associate Dean of Research and Global Engagement, Rammrath Chair in International Business, Co-Faculty Director of the Moran Center for Global Leadership and Professor of MAnagement at the Villanova School of Business. He teaches and does research at the intersection of international business, strategic management and corporate responsibility. Previously, he was on the faculty of American and Georgetown Universities and a trade official with the U.S. government. Jonathan is author or co-author of more than 80 referred articles, 35 chapters and a dozen teaching cases and simulations, and eight books, including International Management: Culture Strategy and Behavior (McGraw-Hill/Irwin), which is in its 11th edition. He has been Associate, Consulting and Chief Editor for numerous journals. He co-developed and taught an interdisciplinary course on the Global Pharmaceutical Industry and is a frequent presenter to health care organizations, including the National Association of Nursing Executives. He holds a Ph.D. in strategic and international management from George Washington University.
Dr. Elmer began his career by earning dual degrees in Chemical Engineering and Biological Sciences from the Missouri University of Science & Technology (formerly University of Missouri – Rolla) in 2007. He then earned his Ph.D. from Ohio State University under the guidance of Dr. Andre F. Palmer in 2011 by completing a dissertation that focused on using recombinant and invertebrate hemoglobins as novel blood substitutes. As a postdoc, he investigated multiple strategies to increase the efficiency of gene therapy treatments in the lab of Dr. Kaushal Rege at Arizona State University. Dr. Elmer in currently continuing his gene therapy research as an Associate Professor at Villanova University. His research mainly focuses on elucidating and manipulating host cell (e.g. T cell) defenses that are activated by the foreign DNA used in gene therapy.
Krisda H. Chaiyachati
Krisda H. Chaiyachati, MD, MPH, MSHP, is an Assistant Professor of Medicine at the Perelman School of Medicine, a Clinical Innovation Manager at Penn Medicine’s Center for Health Care Innovation, Medical Director for Penn Medicine OnDemand Virtual Care, and a Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania. Dr. Chaiyachati designs, studies, and implements innovative strategies towards addressing social barriers to care and improving the accessibility of health care irrespective of patients’ social needs with an eye towards meeting population health goals. Dr. Chaiyachati fundamentally believes that health care delivered solely through conventional face-to-face encounters will continue to create barriers for patients while providers are doomed to face capacity and cost constraints as population health efforts and value-based payment models grow. As the director of OnDemand and a Clinical Innovation Manager, he has an operational and implementation role within Penn Medicine – developing, managing, and steering delivery innovations from pilot to scale. His research projects are focused on reimagining clinician-patient interactions with the support of artificial intelligence and facilitated self-service pathways for conditions, such as hypertension and HIV pre-exposure prophylaxis (PrEP), with evidence-to-practice gaps. Clinically he is a practicing general internist for an on-site employee primary care clinic and advises Penn Medicine’s Human Resources on how employee benefits can be structured to create a healthier workforce.
Kristen A. Feemster
Kristen A. Feemster, MD, MPH, MSHP, is Global Director, Medical Affairs - Pneumococcal Vaccines, Merck & Co., Inc., and Affiliate Physician and resarech Director for the Vaccine Education Center at the Children's Hospitel of Philadelphia (CHOP). Previously, she was Medical Director of the Immunization Program and Acute Communicable Diseases at the Philadelphia Department of Public Health. She trained as a pediatric infectious diseases physician and health services researcher at CHOP and University of Pennsylvania School of Medicine where she has been on faculty since 2010, currently as an adjunct associate professor. Her research interests included vaccine policy and the epidemiology of vaccine preventable diseases. She serves on the board of GE2P2 (Governance, Ethics, Evidence, Policy and Practice) and previously was on the boards of the Pennsylvania and Philadelphia Immunization Coalitions. She is also a technical advisor for the American Academy of Pediatrics Global Immunization Advocacy Initiative working with pediatric societies to support immunization programs in low and middle income countries. Related to her positions and community involvement, Dr. Feemster has authored a book (Vaccines: What Everyone Needs to Know), numerous peer—reviewed manuscripts and invited commentaries and regularly provides vaccine education to a wide range of audiences.
Tracy L. Oliver, Ph.D., RDN, LDN, is an Associate PRofessor in the M. Louise Fitzpatrick College of Nursing at Villanova University. Her research interests concentrate on addressing and reducing weight bias within pre-licensure health professionals to improve the impact on patient delivery and care. She earned her B.s. in Clinical Dietetics and Nutrition from the University of PIttsburgh, and both her Master's and Ph.D. degrees are from Temple University in the field of Kinesiology with a concentration in Exercise Physiology. Tracy currently serves as the Chair of the Weight Management Dietetics Practice group of the Academy of Nutrition and Dietetics.
David Pacitti (Keynote)
David Pacitti is President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers. Based at the U.S. headquarters of Siemens Healthineers in Malvern, Pennsylvania, Pacitti is responsible for leading the marketing, sales, service, and support functions in North America and Latin America, across the entire Healthineers portfolio, including medical imaging, laboratory diagnostics, therapy solutions, and services.
Prior to joining Siemens Healthineers in 2015 in his current role, Pacitti was Division Vice President of U.S. Commercial Operations, Sales, and Marketing at Abbott Vascular for two years, overseeing the company’s business in North America. As a member of the Senior Executive Staff, he worked with the CEO, CFO, and Research & Development team on business development initiatives and played pivotal roles in key launches, including Abbott Vascular’s first drug-eluting stent franchise and structural heart franchise. Prior to this position, Pacitti was Vice President of Abbott Vascular’s Commercial Operations from 2009 to 2013, and Vice President of Global Marketing from 2006 to 2009. He joined Abbott Vascular with its acquisition of Guidant Corp, where he served in positions of increasing responsibility from 1995 to 2006. Early in Pacitti’s career, he was a sales representative in Siemens’ Molecular Imaging business.
Pacitti serves on the boards of Apollo Endo-Surgery, the Advanced Medical Technology Association (AdvaMed), the University City Science Center in Philadelphia, PA, the National Electrical Manufacturers Association (NEMA), and the Siemens Foundation. He is also a member of the CEO Council for Growth at the Chamber of Commerce for Greater Philadelphia, the Children’s Hospital of Philadelphia Corporate Council, the Medical University of South Carolina (MUSC) President’s Advisory Group, and the NextGen Advisory Board for the University of Missouri.
A Philadelphia area native, Pacitti holds a Bachelor of Arts degree with a minor in Economics from Villanova University, where his football prowess earned him induction into the Villanova Varsity Club Hall of Fame in 2006. Following college, he signed a free agent contract in 1990 with the Miami Dolphins as an offensive lineman. The father of three sons and two daughters in addition to being a grandfather, Pacitti resides with his wife and children in West Chester, Pennsylvania.
Dr. Doron Schneider is the Vice President for Population Health Services at Tandigm Health. After completing medical school at UMDNJ and residency at the Deaconess Hospital in Boston, Schneider spent over 20 years at Abington Health where he was the Chief Safety and Quality Officer. Since transitioning to Tandigm in the past year he has continued to focus on improving health in the Delaware Valley through a focus on using data to find, disseminate, diffuse and implement best practices to independent primary care practices.
Rebecca Shenkman, MPH RDN LD, serves as Director for the MacDonald Center for Obesity Prevention and Education. Rebecca has clinical, community and research experience in the field of nutrition providing the Center with a broad perspective on obesity management and research. She is a published author on behavioral treatments of obesity which guided her career focus of translating nutritional science into practical advice for patients and clients to improve their quality of life. Rebecca earned her BA in Psychology from the University of Pennsylvania and her Master of Public Health degree from New York University.
Marian W. Wentworth
Marian W. Wentworth is President and Chief Executive Officer of MSH, a global health nonprofit that makes foundational changes to health systems to protect people from diseases and improve their health. MSH works to strengthen existing health systems. Since joining MSH in 2017, Marian has focused on developing a new strategic vision to guide the organization’s broad, decades-long technical expertise in addressing evolving challenges in leadership, health systems management, human resources, and access to medicines. Marian comes to MSH with over 25 years of experience managing and leading complex international public health initiatives at Merck & Co. At Merck, she led global strategy for marketing, manufacturing and research for the company’s $6 billion dollar vaccines business. A champion for adolescent health, she led the global sales and marketing launch of the world’s first cervical cancer vaccine, Gardasil. She also managed a portfolio of adult vaccines for shingles, influenza, pneumococcal disease, hepatitis B, hepatitis A, and tetanus. Building on her substantial experience in the vaccine market, Marian serves on the Value of Vaccination Research Network (VoVRN) Steering Committee, WHO’s Product Development for Vaccines Advisory Committee (PDVAC), the Measles Rubella Microarray Patch Committee (MR-MAP), and the WHO Malaria Vaccine Committee (MALVAC). Marian has worked extensively with major policy decision-makers including Gavi, the World Health Organization, the Bill & Melinda Gates Foundation and various ministries of health. She has a B.A. in mathematics from Harvard University and spent her early career as a consultant in operations management at Arthur D. Little, Inc.